- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Wayne Jonas Discusses the Role of Integrative Health in Treating Pain
Wayne Jonas, MD, executive director of Samueli Integrative Health Programs at H&S Ventures, discusses how integrative health practices can help treat patients with pain.
Transcript
What role does integrative health play in helping patients manage pain?
So, I that's a great question. And I would say that the short answer is that integrative health practices and nonpharmacological approaches for chronic pain have a central role. All you have to do is look at the current national guidelines from almost anywhere—the American College of Physicians, the CDC, the NIH [National Institute of Health], JCAHO [Joint Commission on Accreditation of Healthcare Organizations]—they all recommend that non pharmacological approaches and be integrated with standard conventional drug approaches for the treatment of chronic pain. And in fact, many of them say that for many chronic conditions, they should be the lead approach for chronic pain.
And so, I think that it's imperative for anybody that deals with people with chronic pain—And that's a lot of people. There's 100 million people in the country that suffer with chronic pain—that they learn these skills and they make them a part of their standard practice.
Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL
December 26th 2024A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.
Listen
HS Treatment Goals: Better Quality of Life, Not Just Control
January 3rd 2025For part 3 of our discussion with Chris Sayed, MD, we tackle several important topics in the hidradenitis suppurative (HS) and inflammatory disease space: patient quality of life, medication and treatment goals, and the possibility of a cure.
Read More
Dr Yehuda Handelsman: DCRM Guidelines Are Shaping Integrated, Global CRM Care
January 3rd 2025In part 2 of our interview, Yehuda Handelsman, MD, discusses how cardiorenalmetabolic (CRM) disease management is advancing with the 2022 Diabetes, Cardiorenal, and Metabolic (DCRM) multispecialty practice recommendations and the updated DCRM 2.0 guidelines.
Read More
Stripped of Fucose, Powerful Monoclonal Antibody Shows Promising Results in MDS Dosing Study
January 2nd 2025Nicole Grieselhuber, MD, PhD, of The Ohio State University, discusses results from Part D of a dosing study involving patients with previously untreated higher-risk myelodysplastic syndrome (MDS) who were treated with a combination of SEA-CD70 and azacitidine.
Read More
